Articles

Pharma Marketing News is the monthly e-newsletter of the Pharma Marketing Network (www.pharma-mkting.com). It is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help susbcribers keep up to date on best practices and network with their peers.

To usher in the New Year, it's traditional for pundits like Pharmaguy (aka John Mack, Publisher of Pharma Marketing News) to go out on a limb and make a few pharma industry predictions for the year. To compile his list, Pharmaguy used data from surveys, interviewed a pharmaceutical executive, and looked at the past year as an indication of what may be important in 2013 and beyond.

You know the Tale of Two Cities. This article, however, tells the Tale of Two Books: Bad Pharma, a 430-page book by Ben Goldacre, a British physician, whose previous book, Bad Science, was a best seller in the non-fiction realm and the much smaller 123-page book Devalued and Distrusted by John L. LaMattina, former president of research and develop at Pfizer.

Welcome to Volume 11, Issue #11 (27 December 2012) of Pharma Marketing News.

These are Pharmaguy's favorite images and stories published on Pharma Marketing Blog during 2012. It's a good summary of some of the major trends in the industry.

Google launched a new drug search result format that includes data from the U.S. FDA, the National Library of Medicine, and the Department of Veterans Affairs, among othersbut apparently not directly from pharmaceutical companies.

There are enough legal issues in this case to keep a boatload of constitutional and pharma lawyers busy for years. But let's look at this from a different perspective -- i.e., what pharma has to gain from this and what patients have to lose.

What's at Stake in the Off-Label Debate Freedom of speech may be the legal issue, but enhancing the bottom line is the business issueIn...

On the one hand, there's the physician who's looking for 'evidence' that diabetes is being managed. On the other hand is the patient argument that 'emotional support' is also a key benefit. One could argue that BOTH sides have merit.

The Role of Social Media in Managaing Chronic Diseases Focus on Diabetes and ObesityIn an "Open letter to NPR about Diabetes Social Media piece,"...